1. Home
  2. KNDI vs ALVOW Comparison

KNDI vs ALVOW Comparison

Compare KNDI & ALVOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNDI
  • ALVOW
  • Stock Information
  • Founded
  • KNDI 2002
  • ALVOW 2013
  • Country
  • KNDI China
  • ALVOW Luxembourg
  • Employees
  • KNDI N/A
  • ALVOW 999
  • Industry
  • KNDI Auto Manufacturing
  • ALVOW Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • KNDI Consumer Discretionary
  • ALVOW Health Care
  • Exchange
  • KNDI Nasdaq
  • ALVOW Nasdaq
  • Market Cap
  • KNDI N/A
  • ALVOW N/A
  • IPO Year
  • KNDI N/A
  • ALVOW N/A
  • Fundamental
  • Price
  • KNDI $1.33
  • ALVOW $1.36
  • Analyst Decision
  • KNDI
  • ALVOW
  • Analyst Count
  • KNDI 0
  • ALVOW 0
  • Target Price
  • KNDI N/A
  • ALVOW N/A
  • AVG Volume (30 Days)
  • KNDI 169.5K
  • ALVOW 15.0K
  • Earning Date
  • KNDI 05-15-2025
  • ALVOW 02-27-2025
  • Dividend Yield
  • KNDI N/A
  • ALVOW N/A
  • EPS Growth
  • KNDI N/A
  • ALVOW N/A
  • EPS
  • KNDI N/A
  • ALVOW N/A
  • Revenue
  • KNDI $118,127,232.00
  • ALVOW $393,919,000.00
  • Revenue This Year
  • KNDI N/A
  • ALVOW N/A
  • Revenue Next Year
  • KNDI N/A
  • ALVOW N/A
  • P/E Ratio
  • KNDI N/A
  • ALVOW N/A
  • Revenue Growth
  • KNDI N/A
  • ALVOW 517.92
  • 52 Week Low
  • KNDI $0.89
  • ALVOW $2.33
  • 52 Week High
  • KNDI $2.98
  • ALVOW $2.33
  • Technical
  • Relative Strength Index (RSI)
  • KNDI 43.30
  • ALVOW N/A
  • Support Level
  • KNDI $1.31
  • ALVOW N/A
  • Resistance Level
  • KNDI $1.47
  • ALVOW N/A
  • Average True Range (ATR)
  • KNDI 0.09
  • ALVOW 0.00
  • MACD
  • KNDI -0.03
  • ALVOW 0.00
  • Stochastic Oscillator
  • KNDI 7.69
  • ALVOW 0.00

About ALVOW Alvotech Warrant

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.

Share on Social Networks: